[Urolesan in the treatment of stenocardia patients].

Abstract	Urolesan was used in the treatment of patients with chronic ischemic heart disease. It was established that urolesan favours improvement of the state of the vascular component of microcirculation, aggregation of erythrocytes, increase of the peripheral circulation, normalization of the blood coagulation system, optimization of external respiration, normalization of the activity of serum aminotransferases. These changes were particularly pronounced in exertion stenocardia.
Authors	E M Neĭko, Z V Duma, Iu V Del'va, B Iu Shpak, M V Debenko
Journal	Vrachebnoe delo (Vrach Delo) Issue 11 Pg. 57-9 (Nov 1989) ISSN: 0049-6804 [Print] Ukraine
Vernacular Title	Urolesan v lechenii bol'nykh stenokardieĭ.
PMID	2609587 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References	Plant Extracts urolesan Dipyridamole
Topics	Angina Pectoris (drug therapy, physiopathology) Chronic Disease Coronary Disease (drug therapy, physiopathology) Dipyridamole (therapeutic use) Drug Evaluation Drug Therapy, Combination Humans Physical Exertion Plant Extracts (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!